✦ LIBER ✦

6062 NGR-hTNF, a vascular targeting agent (VTA), administered as single agent in patients (pts) with colorectal cancer (CRC) failing standard regimens: a phase II study

✍ Scribed by Rimassa, L.; Santoro, A.; Sobrero, A.F.; Sclafani, F.; Gregorc, V.; Andretta, V.; Tronconi, M.C.; Cappio, F. Caligaris; Lambiase, A.; Bordignon, C.

Book ID: 122057473
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 48 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71157-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6066 Phase II study of two doses of NGR-

6066 Phase II study of two doses of NGR-hTNF, a vascular targeting agent (VTA), combined with capecitabine/oxaliplatin (XELOX) in colorectal cancer (CRC) patients failing standard regimens

✍ Sobrero, A.F.; Pessino, A.; Andretta, V.; Bennicelli, E.; Fornarini, G.; Caprion 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

6617 Phase II study of NGR-hTNF, a selec

6617 Phase II study of NGR-hTNF, a selective vascular targeting agent (VTA), in previously treated patients (pts) with advanced hepatocellular carcinoma (HCC)

✍ Santoro, A.; Citterio, G.; Pressiani, T.; Gregorc, V.; Rimassa, L.; De Braud, F. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

1228 Phase I study of NGR-hTNF, a vascul

1228 Phase I study of NGR-hTNF, a vascular targeting agent (VTA), in combination withcisplatin in refractory patients (pts) with solid tumours

✍ G. Citterio; F.G. De Braud; V. Gregorc; T.M. De Pas; C. Noberasco; S. Boselli; M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Phase II study of NGR-hTNF, a selective

Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy

✍ Armando Santoro; Lorenza Rimassa; Alberto F. Sobrero; Giovanni Citterio; Frances 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 206 KB

9011 NGR-hTNF, a vascular targeting agen

9011 NGR-hTNF, a vascular targeting agent (VTA), in previously treated patients with malignant pleural mesothelioma (MPM): a phase II study

✍ Gregorc, V.; Ceresoli, G.L.; Zucali, P.A.; De Braud, F.G.; Bajetta, E.; Santoro, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB